Extrafollicular IgD-CD27-CXCR5-CD11c- DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19

Cell Rep. 2023 Jun 27;42(6):112630. doi: 10.1016/j.celrep.2023.112630. Epub 2023 May 30.

Abstract

Although therapeutic B cell depletion dramatically resolves inflammation in many diseases in which antibodies appear not to play a central role, distinct extrafollicular pathogenic B cell subsets that accumulate in disease lesions have hitherto not been identified. The circulating immunoglobulin D (IgD)-CD27-CXCR5-CD11c+ DN2 B cell subset has been previously studied in some autoimmune diseases. A distinct IgD-CD27-CXCR5-CD11c- DN3 B cell subset accumulates in the blood both in IgG4-related disease, an autoimmune disease in which inflammation and fibrosis can be reversed by B cell depletion, and in severe COVID-19. These DN3 B cells prominently accumulate in the end organs of IgG4-related disease and in lung lesions in COVID-19, and double-negative B cells prominently cluster with CD4+ T cells in these lesions. Extrafollicular DN3 B cells may participate in tissue inflammation and fibrosis in autoimmune fibrotic diseases, as well as in COVID-19.

Keywords: B cell depletion in disease; COVID-19 pathogenesis; CP: Immunology; DN3 B cells; IgG4-related disease; T-B collaboration in disease; double-negative B cells; extrafollicular B cells; inflammatory fibrosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocyte Subsets* / metabolism
  • B-Lymphocyte Subsets* / pathology
  • COVID-19*
  • Fibrosis
  • Humans
  • Immunoglobulin D
  • Immunoglobulin G4-Related Disease*
  • Inflammation
  • Receptors, CXCR5

Substances

  • CXCR5 protein, human
  • Immunoglobulin D
  • Receptors, CXCR5